(Yicai) March 23 -- For more than a decade, the promise of artificial intelligence in biotechnology has centered on discovery ...
The acting director of the Centers for Disease Control and Prevention has delayed publication of a CDC report showing the ...
Morning Overview on MSN
Once-controversial exon-skipping drugs return as hope for Duchenne
Exon-skipping therapies for Duchenne muscular dystrophy, a class of drugs that triggered fierce regulatory debate when they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results